

Tropisetron
22,00 € – 40,00 €
Note: For research and educational purposes only. Not intended for human consumption.
Tropisetron is a well-studied compound known for its dual action as a 5-HT₃ serotonin receptor antagonist and a partial alpha7 nicotinic acetylcholine receptor agonist. Originally developed for antiemetic support, it has also gained interest in nootropic and neuroprotective research for its potential to support cognitive clarity, mood balance, and neuroinflammation modulation.
i) Primary Pharmacological Actions of Tropisetron :
Absolutely. Tropisetron is a compound with dual pharmacological activity — both in serotonin and cholinergic systems — which makes it interesting for both clinical and nootropic research.
🧠 Tropisetron: Neurotransmitter Activity & Pharmacological Actions
🔹 1. 5-HT₃ (Serotonin) Receptor Antagonist
-
Primary action: Antagonist of 5-HT₃ receptors, which are ionotropic serotonin receptors.
-
Found in both the central nervous system and gastrointestinal tract.
-
Clinical effect: Used to reduce nausea and vomiting, particularly in chemotherapy or post-operative contexts.
⚠️ Not an agonist of serotonin receptors — it’s an antagonist that blocks 5-HT₃ stimulation.
🔹 2. α7 Nicotinic Acetylcholine Receptor (α7-nAChR) – Partial Agonist
-
Secondary action: Acts as a partial agonist at alpha7 nicotinic acetylcholine receptors.
-
These receptors are involved in:
-
Cognition and memory
-
Anti-inflammatory signaling (especially in the brain and immune cells)
-
Neuroplasticity and neuroprotection
-
✅ This is where tropisetron may exert nootropic and neuroprotective effects.
⚙️ Other Pharmacological Properties
🔸 Anti-inflammatory (CNS)
-
Through α7-nAChR activation and modulation of microglia, tropisetron may help suppress neuroinflammation, a mechanism relevant in Alzheimer’s, Parkinson’s, and mood disorders.
🔸 Glutamatergic Modulation
-
By modulating α7-nAChRs, tropisetron may indirectly affect glutamate release and NMDA receptor function, impacting learning and excitotoxicity.
🔸 Potential Antidepressant Effects
-
Emerging evidence suggests mood-stabilizing effects in animal models, possibly through its serotonergic modulation and cholinergic balance.
🧬 Summary Table
Target Receptor | Action | Effect |
---|---|---|
5-HT₃ (Serotonin) | Antagonist | Anti-nausea, mood regulation |
α7-nicotinic ACh receptor | Partial Agonist | Pro-cognitive, neuroprotective |
Glutamate (indirect) | Modulation via α7-nAChR | Learning, excitability control |
Microglial cells (immune) | Indirect modulation | Anti-inflammatory |
📏 Typical Dosage Guidelines (For Research Use Only)
Use Context | Common Dose Range |
---|---|
Antiemetic (clinical) | 5–10 mg/day (oral) |
Nootropic Research | 0.5–5 mg/day (oral) |
Neuroinflammation models | 1–10 mg/day (oral/injection in animal studies) |
✅ Lower doses (0.5–3 mg) are typically explored for cognitive and neuroinflammatory modulation in experimental models.
⚠️ Clinical antiemetic use typically involves single 5–10 mg doses.
⏱️ Pharmacokinetics
-
Half-life: ~6–8 hours
-
Bioavailability: ~60% (oral)
-
Onset: ~30–60 minutes
-
**Duration of action
Συσκευασία |
250 mg. ,500 mg |
---|
TECHNICAL SPECIFICATIONS :
Synephrine 98%
Ideal storage is done in a cool and dry place, away from direct sunlight and heat. Has to be labeled clearly at all times and be kept out of reach of children!
WHAT TO AVOID :
-
Other serotonergic drugs: Combining tropisetron with SSRIs, SNRIs, MAOIs, or other 5-HT₃ antagonists can increase the risk of serotonin syndrome.
-
QT-prolonging drugs: Avoid combining with drugs that prolong the QT interval (e.g., some antiarrhythmics, antipsychotics, macrolide antibiotics) due to risk of arrhythmias.
-
CYP2D6 inhibitors: May affect tropisetron metabolism (e.g., fluoxetine, paroxetine), potentially increasing effects or side effects.
- Prolonged QT syndrome or heart arrhythmias: Use with caution or avoid entirely due to risk of cardiac issues.
DISCLAIMER :
As stated in the short description, this and other products of subsection of “Nootropics” in our e-shop are NOT intended for human consumption! Those products are available for collection purposes or for other lawful use for which the consumer has taken care to be explicitly informed on a personal level in every aspect that may be affecting them.
The information provided in the descriptions of products which can be found in “Nootropics” subsection – as available from ethosherbals.com, SMARTSHOP Main Category – is of an academic nature. This information is not intended to be used for human consumption of the products in question. It is not intended to diagnose, prevent or treat any medical condition. It is not intended to be a substitute for any medical treatment.
Πρέπει να είστε συνδεδεμένοι για να δημοσιεύσετε μια κριτική.
Αξιολογήσεις
Δεν υπάρχει καμία αξιολόγηση ακόμη.